Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19Liam Gaziano, Jacob Joseph, Dennis Valentine et al.|Nature Medicine|2021Cited by 248
Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failureDanielle Rasooly, Juan P. Casas, Gina M. Peloso et al.|Nature Communications|2023Cited by 130
Actionable druggable genome-wide Mendelian randomization identifies repurposing opportunities for COVID-19Liam Gaziano, Kelly Cho, Claudia Giambartolomei et al.|medRxiv|2020Cited by 23
Large-scale multi-omics identifies drug targets for heart failure with reduced and preserved ejection fractionDanielle Rasooly, Jacob Joseph, Claudia Giambartolomei et al.|Nature Cardiovascular Research|2025Cited by 19
Genome-wide association analysis and Mendelian randomization proteomics identify drug targets for heart failureDanielle Rasooly, Juan P. Casas, Gina M. Peloso et al.|medRxiv|2022Cited by 10